OR Royalties Inc. (NYSE:OR) Given Average Recommendation of “Moderate Buy” by Analysts

Shares of OR Royalties Inc. (NYSE:OR) have been assigned an average recommendation of “Moderate Buy” from the nine ratings firms that are presently covering the company, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating on the company. The average 1-year target price among analysts that have issued a report on the stock in the last year is $35.75.

A number of brokerages recently weighed in on OR. Jefferies Financial Group reissued a “hold” rating and set a $38.00 target price on shares of OR Royalties in a research note on Sunday, December 7th. Weiss Ratings reissued a “buy (b)” rating on shares of OR Royalties in a research report on Monday, December 29th. Wall Street Zen raised OR Royalties from a “buy” rating to a “strong-buy” rating in a research note on Saturday. Zacks Research cut OR Royalties from a “strong-buy” rating to a “hold” rating in a research note on Friday, December 19th. Finally, Raymond James Financial upgraded OR Royalties from a “market perform” rating to an “outperform” rating and set a $41.00 target price for the company in a report on Thursday, November 6th.

Institutional Investors Weigh In On OR Royalties

A number of large investors have recently bought and sold shares of OR. Cetera Investment Advisers increased its stake in OR Royalties by 3.5% in the second quarter. Cetera Investment Advisers now owns 13,147 shares of the basic materials company’s stock valued at $337,000 after purchasing an additional 440 shares in the last quarter. Vident Advisory LLC grew its stake in shares of OR Royalties by 2.0% in the 2nd quarter. Vident Advisory LLC now owns 42,349 shares of the basic materials company’s stock valued at $1,089,000 after buying an additional 820 shares during the period. HighTower Advisors LLC increased its position in OR Royalties by 1.4% in the 3rd quarter. HighTower Advisors LLC now owns 79,518 shares of the basic materials company’s stock valued at $3,187,000 after buying an additional 1,088 shares in the last quarter. Vanguard Personalized Indexing Management LLC increased its position in OR Royalties by 9.6% in the 3rd quarter. Vanguard Personalized Indexing Management LLC now owns 16,471 shares of the basic materials company’s stock valued at $660,000 after buying an additional 1,446 shares in the last quarter. Finally, Allspring Global Investments Holdings LLC raised its stake in OR Royalties by 0.5% during the 2nd quarter. Allspring Global Investments Holdings LLC now owns 283,500 shares of the basic materials company’s stock worth $7,291,000 after buying an additional 1,500 shares during the period. 68.52% of the stock is currently owned by institutional investors and hedge funds.

OR Royalties Price Performance

Shares of OR opened at $36.79 on Wednesday. The business has a 50-day moving average of $34.19 and a 200-day moving average of $32.85. The company has a market capitalization of $6.92 billion, a price-to-earnings ratio of 46.56 and a beta of 0.78. OR Royalties has a 1 year low of $17.55 and a 1 year high of $42.25.

OR Royalties (NYSE:OR) last released its earnings results on Wednesday, November 5th. The basic materials company reported $0.22 earnings per share for the quarter, beating analysts’ consensus estimates of $0.19 by $0.03. The business had revenue of $71.63 million during the quarter, compared to the consensus estimate of $53.85 million. OR Royalties had a net margin of 60.72% and a return on equity of 10.67%. As a group, sell-side analysts anticipate that OR Royalties will post 0.62 EPS for the current year.

OR Royalties Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, January 15th. Stockholders of record on Wednesday, December 31st will be paid a $0.055 dividend. The ex-dividend date is Wednesday, December 31st. This represents a $0.22 annualized dividend and a dividend yield of 0.6%. OR Royalties’s payout ratio is currently 27.85%.

About OR Royalties

OR Royalties PLC (NYSE: OR) is a closed-ended investment company that specializes in acquiring and managing royalty interests in life science and pharmaceutical products. The company provides capital to biotechnology, specialty pharmaceutical and medical device companies in exchange for a share of future sales revenues. By focusing on royalties secured against marketed products, OR Royalties aims to deliver income and growth potential while minimizing the development and commercialization risks typically associated with direct equity stakes.

The company’s core activities include sourcing royalty transactions, structuring bespoke financing solutions and actively monitoring a diversified portfolio of assets.